Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125388
Filing Date
2024-11-12
Accepted
2024-11-12 16:10:29
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-20240930.htm   iXBRL 10-Q 3203028
2 EX-31.1 fgen-ex31_1.htm EX-31.1 9480
3 EX-31.2 fgen-ex31_2.htm EX-31.2 9468
4 EX-32.1 fgen-ex32_1.htm EX-32.1 9006
  Complete submission text file 0000950170-24-125388.txt   11434228

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20240930.xsd EX-101.SCH 1746158
78 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20240930_htm.xml XML 1788200
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 241448185
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)